(Reuters) - Canadian eye drug developer QLT Inc said six of the seven directors elected at the company's annual general meeting on Monday were nominees of a dissident shareholder. Last month, QLT had ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback